Navigation Links
Colon Cancer Death Rate Doubles As Patients Stop Chemotherapy

In a first ever study conducted to by researchers at Columbia University Medical Center to analyze the link between colon cancer death rates and adherence to cancer treatment, //it has been found that nearly one third of the patients had stopped their chemotherapy. More specifically, stage III colon cancer patients who were prescribed a combination of leucovorin and 5-fluorouracil for 6 months, were found to stop their treatment before completion.

Non-compliance rates in this were as high as 30%. Although previous studies have shown that not adhering to the chemotherapy regimen is associated with shorter survival rates. Moreover, it equates to being offered no treatment at all. Despite this fact, colon cancer patients fail to take the issue seriously. The researchers have therefore urged all colon cancer patients to complete their chemotherapy regime, to reap the maximum benefit of the cancer treatment.

‘The intuitive thinking is that if you complete most of a treatment regimen, you should get most of the treatment benefit. But these findings are significant because they indicate that completing treatment is as critical for colon cancer as it is for breast cancer – and we need to do better to ensure that patients who can, complete treatment as intended,’ said Alfred I. Neugut, M.D., Ph.D., who led the study along with Dawn L. Hershman, M.D., M.S.

The study will be published in the May 20, 2006 issue of the Journal of Clinical Oncology (published online April 17, 2006).

The research team used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to identify stage III colon cancer patients who were at least 65 years of age or older, and who received one to seven months of fluorouracil (FU)-based adjuvant chemotherapy treatment.

Among the 1,579 patients who survived eight months or longer, the 1,091 (69.1 percent) who underwent five to seven months of treatment survived nearly twice as long as the 488 (30.9 percent) who received only one to four months of treatment. Patients, who were older, unmarried and had comorbid conditions, were more likely to receive less than five months of treatment.

The same research team recently published (Journal of Clinical Oncology, Sept. 20, 2005 issue) the first study to link treatment completion issues with race and poor survival rates. The 2005 study found that black women with early stage breast cancer were more likely than their counterparts of other races to abandon chemotherapy before completing their full course of treatment. The findings shed new light on why breast black cancer patients experience lower survival rates than other women, despite a lower incidence.

Source: Eurekalert
'"/>




Related medicine news :

1. Cancers of Colon & Rectum linked to Cigarette Smoking
2. Need for Colon cancer screening
3. Beer guards against Colon Cancer
4. Important substance in curry conciliate Inflamed Colon
5. Colon cancer linked with common virus
6. Colon cancer risk linked to genes causing Hemochromatosis
7. Death Risk Higher in Obese Women with Colon Cancer
8. Inflammation Linked to Colon Cancer
9. Aspirin Found To Reduce The Risk Of Colon Cancer
10. Blood Marker Found To Predict Colon Cancer
11. Estrogen Found To Protect the Colon Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... ... ... Today, Bright Pink , a national breast and ovarian health non-profit ... proactively at a young age. 1 in 8 women will develop breast cancer ... can save lives-but only if young women are proactive with their health. Bright Pink’s ...
(Date:2/28/2017)... ... 2017 , ... Science-based sleep company Level Sleep ... HCI students, faculty, and alumni can acquire Level Sleep’s unique sleep system in ... community to receive educational content on sleep and proper biomechanics that will empower ...
(Date:2/28/2017)... ... 28, 2017 , ... Las Vegas Skin and Cancer Clinic (LVSCC) is proud ... 10, 2017, 4-7 pm PST. For more than six decades, LVSCC has provided the ... Rancho neighborhood, has been renovated to provide medical and cosmetic dermatological products and services. ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... a healthcare automation intelligence company based in New York. , “Ensuring an intuitive, ... provider’s workflow remains unaltered. Those two fundamental reasons are the reasons this acquisition ...
(Date:2/28/2017)... ... February 28, 2017 , ... The role of females ... from military to civilian life. Body image dissatisfaction is largely unexamined among female ... and greater occurrence of chronic mental health conditions than female civilians. Female veterans ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017  A landmark study led ... MBBS, PhD, FRACS, of  Sydney Heart and Lung ... will be published in the February 28, 2017 issue ... College of Cardiology . According to the study, which involved 37,720 ... surgery technique (anOPCABG) reduced postoperative stroke by ...
(Date:2/27/2017)... TAMPA, Fla. , Feb. 27, ... medical device company focused on developing cerebral embolic ... the members of the FDA,s Circulatory System Devices ... acknowledgement of the need for cerebral protection following ... "The statements shared by this FDA panel support ...
(Date:2/27/2017)... -- Now in its seventh year, the Pharmaceutical ... successful at developing and commercialising innovation. ... The Index can be summarised ... two different companies in early phase, which would make the ... of each company,s performance between 2011 and 2016, the 2017 ranking sees ...
Breaking Medicine Technology: